Next Article in Journal
Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients
Previous Article in Journal
Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies
Previous Article in Special Issue
Hypidone Hydrochloride (YL-0919), a Sigma-1 Receptor Agonist, Improves Attention by Increasing BDNF in mPFC
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(5), 700; https://doi.org/10.3390/ph18050700
Action Date Notes Link
article xml file uploaded 9 May 2025 10:58 CEST Original file -
article xml uploaded. 9 May 2025 10:58 CEST Update https://www.mdpi.com/1424-8247/18/5/700/xml
article pdf uploaded. 9 May 2025 10:58 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/700/pdf
article html file updated 9 May 2025 11:00 CEST Original file -
article html file updated 25 June 2025 03:39 CEST Update https://www.mdpi.com/1424-8247/18/5/700/html
Back to TopTop